Analysis of Global Burden of Disease data spanning 1990-2023 reveals that childhood and adolescent asthma cases have reached 131 million globally, with an age-standardized prevalence rate of 1,789.9 per 100,000. While both prevalence and incidence rates continue climbing, mortality and disability-adjusted life years are declining, suggesting improved disease management despite growing case numbers. The study identifies concerning gender disparities: males bear greater disease burden in the 0-14 age group, while females face higher burden during adolescence (15-19 years). This pattern reflects hormonal influences on asthma expression and potentially differential healthcare access or treatment responses across developmental stages. The findings illuminate a critical paradox in pediatric respiratory health—more children developing asthma but fewer dying from it, likely reflecting better diagnostic capabilities, improved treatments, and enhanced healthcare access in many regions. However, projections through 2038 warn of rising female mortality rates, demanding targeted interventions. As a preprint awaiting peer review, these conclusions require validation, but the comprehensive 33-year analysis using established GBD methodology provides robust evidence for policymakers addressing this growing global health challenge affecting over 130 million young lives.